Abstract

BackgroundNumerous host cellular factors are exploited by viruses to facilitate infection. Our previous studies and those of others have shown heat-shock protein 90 (Hsp90), a cellular molecular chaperone, is involved in herpes simplex virus (HSV)-1 infection. However, the function of the dominant Hsp90 isoform and the relationship between Hsp90 and HSV-1 α genes remain unclear.Methods and resultsHsp90α knockdown or inhibition significantly inhibited the promoter activity of HSV-1 α genes and downregulated virion protein 16(VP16) expression from virus and plasmids. The Hsp90α knockdown-induced suppression of α genes promoter activity and downregulation of α genes was reversed by VP16 overexpression, indicating that Hsp90α is involved in VP16-mediated transcription of HSV-1 α genes. Co-immunoprecipitation experiments indicated that VP16 interacted with Hsp90α through the conserved core domain within VP16. Based on using autophagy inhibitors and the presence of Hsp90 inhibitors in ATG7−/− (autophagy-deficient) cells, Hsp90 inhibition-induced degradation of VP16 is dependent on macroautophagy-mediated degradation but not chaperone-mediated autophagy (CMA) pathway. In vivo studies demonstrated that treatment with gels containing Hsp90 inhibitor effectively reduced the level of VP16 and α genes, which may contribute to the amelioration of the skin lesions in an HSV-1 infection mediated zosteriform model.ConclusionOur study provides new insights into the mechanisms by which Hsp90α facilitates the transactivation of HSV-1 α genes and viral infection, and highlights the importance of developing selective inhibitors targeting the interaction between Hsp90α and VP16 to reduce toxicity, a major challenge in the clinical use of Hsp90 inhibitors.

Highlights

  • Numerous host cellular factors are exploited by viruses to facilitate infection

  • Our study provides new insights into the mechanisms by which Hsp90α facilitates the transactivation of herpes simplex virus (HSV)-1 α genes and viral infection, and highlights the importance of developing selective inhibitors targeting the interaction between Hsp90α and virion protein 16 (VP16) to reduce toxicity, a major challenge in the clinical use of heat-shock protein 90 (Hsp90) inhibitors

  • Hsp90α is involved in modulating the promoter activity of HSV-1 α genes Our previous studies showed that Hsp90 inhibition greatly attenuates HSV-1 infection and the expression of HSV-1 α genes (Xiang et al, 2012a; Zhong et al, 2014)

Read more

Summary

Introduction

Our previous studies and those of others have shown heat-shock protein 90 (Hsp90), a cellular molecular chaperone, is involved in herpes simplex virus (HSV)-1 infection. Hsp has four major isoforms, Hsp90α, Hsp90β, tumor necrosis factor receptor-associated protein 1, and 94-kDa glucose-regulated protein (GRP94) (Whitesell & Lindquist, 2005). The majority of viruses, such as EV71, HIV-1, and hepatitis B virus (HBV), utilize these two isoforms (Burch & Weller, 2005; Whitesell & Lindquist, 2005; Wang et al, 2013; Reyes-Del Valle et al, 2005; Voss et al, 2000). GRP94 can be utilized by hepatitis C virus to inhibit the host immune system response and block viral-induced apoptosis (Song et al, 2008)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call